Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells.
about
Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.Curcumin Reactivates Silenced Tumor Suppressor Gene RARβ by Reducing DNA Methylation.Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis.Curcumin mediated down-regulation of αV β3 integrin and up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) in Erlotinib resistant SW480 colon cancer cells.Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1.Curcumin Suppresses MAPK Pathways to Reverse Tobacco Smoke-induced Gastric Epithelial-Mesenchymal Transition in Mice.
P2860
Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Coadministration of erlotinib ...... iability in lung cancer cells.
@en
Coadministration of erlotinib ...... iability in lung cancer cells.
@nl
type
label
Coadministration of erlotinib ...... iability in lung cancer cells.
@en
Coadministration of erlotinib ...... iability in lung cancer cells.
@nl
prefLabel
Coadministration of erlotinib ...... iability in lung cancer cells.
@en
Coadministration of erlotinib ...... iability in lung cancer cells.
@nl
P2093
P2860
P356
P1476
Coadministration of erlotinib ...... viability in lung cancer cells
@en
P2093
Hiroaki Nomori
Jun Yamamoto
Yotaro Izumi
P2860
P304
P356
10.1002/PTR.5056
P577
2013-08-13T00:00:00Z